Genetics

This blog post reviews a prospective, longitudinal analysis from the GEMS (Genes and Environment in Multiple Sclerosis) cohort assessing whether primary prevention trials for multiple sclerosis are scientifically and operationally feasible. Focusing on first-degree relatives of individuals with MS, the article summarizes observed conversion rates to clinically diagnosed MS over long-term follow-up, evaluates risk enrichment using an integrated Genetic and Environmental Risk Score (GERS), and examines participant willingness to enroll in prevention studies under different risk scenarios and intervention types. The discussion highlights how combining familial recruitment with risk stratification and earlier biomarkers (e.g., MRI and fluid markers) could enable adequately powered prevention trials, while also addressing key limitations—such as modest converter counts and the need for imaging-confirmed presymptomatic disease states—to guide the next generation of MS prevention research.